Alpha Cognition (ACOG) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual General Meeting scheduled for June 19, 2025, at 9:00 am Central Time in Grapevine, TX.
Proxy materials, including the proxy statement and annual report, are available online and by request.
Shareholders are encouraged to review all proxy materials before voting.
Voting matters and shareholder proposals
Shareholders will vote on setting the number of directors, electing directors, appointing independent auditors, and approving the 2025 Stock and Incentive Plan.
Board recommends voting "FOR" all proposals and director nominees.
Board of directors and corporate governance
Election of directors is a key agenda item for the meeting.
The number of directors constituting the board will be set by shareholder vote.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Alpha Cognition
- FDA-approved ZUNVEYL launches in March, targeting LTC Alzheimer's with improved tolerability.ACOG
Investor Update9 Jan 2026 - ZUNVEYL launched in US, $52.8M raised, and strong liquidity supports global expansion.ACOG
Q4 202427 Dec 2025 - Biopharma seeks up to $250M to fund Alzheimer's drug launch and pipeline, with $75M ATM offering.ACOG
Registration Filing16 Dec 2025 - 2.38M shares registered for resale; ZUNVEYL launch and Asia-Pacific deal drive growth.ACOG
Registration Filing16 Dec 2025 - ZUNVEYL's launch and Asia-Pacific licensing drive growth amid ongoing net losses and Nasdaq listing.ACOG
Registration Filing16 Dec 2025 - ZUNVEYL targets major growth in 2026 with new data, expanded access, and global milestones.ACOG
Fireside Chat3 Dec 2025 - Key votes on board, auditor, and new equity plan highlight governance and compensation focus.ACOG
Proxy Filing2 Dec 2025 - Shareholders can request financial statements by mail or online for greater transparency.ACOG
Proxy Filing2 Dec 2025 - IPO funds will support the U.S. launch of an Alzheimer's drug, but financial risks remain high.ACOG
Registration Filing29 Nov 2025